Cargando…
Recombinant interleukin-2 stimulates lymphocyte recovery in patients with severe COVID-19
A recently identified type of pneumonia, referred to as coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus-2, has rapidly spread worldwide. Lymphopenia and a proinflammatory cytokine storm frequently occur in patients with severe COVID-19. However,...
Autores principales: | Zhu, Meng-En, Wang, Qian, Zhou, Shaoqiong, Wang, Bin, Ke, Li, He, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851620/ https://www.ncbi.nlm.nih.gov/pubmed/33603836 http://dx.doi.org/10.3892/etm.2021.9658 |
Ejemplares similares
-
Cytological Characteristics of Human Glioma‐infiltrating Lymphocytes Stimulated with Recombinant Interleukin 2 and an Anti‐CD3 Antibody
por: Kikuchi, Teturo, et al.
Publicado: (1991) -
Rescue and evaluation of a recombinant PRRSV expressing porcine Interleukin-4
por: Li, Zhijun, et al.
Publicado: (2015) -
Influence of tumour physico-chemical conditions on interleukin-2-stimulated lymphocyte proliferation.
por: Loeffler, D. A., et al.
Publicado: (1992) -
Prolonged enhancement of cytotoxic T lymphocytes in the post-recovery state of severe COVID-19
por: Mitsuyama, Yumi, et al.
Publicado: (2021) -
Elevated interleukin‐6, interleukin‐10 and neutrophil : lymphocyte ratio as identifiers of severe coronavirus disease 2019
por: Godkin, Andrew, et al.
Publicado: (2020)